DSD-T309

Congenital Adrenal Hyperplasia (CAH) · 46,XX · DSD-T309

DSD-T309 · Sex chromosome DSD · 2023 · Automated translation

Genes SRY · Karyotype 46,XX · Phenotypes HPO:0000135, HPO:0000771, Hypogonadism (HP:0000135), Gynecomastia (HP:0000771)

46,XY DSD due to 3β-hydroxysteroid dehydrogenase type 2 deficiency (classic salt-wasting form).

Case fields and evidence

Category

Congenital Adrenal Hyperplasia (CAH)

Age

Neonate (initial workup on day 3 of life, hyponatremia on day 18)

Sex

Male (male sex of rearing, 46,XY)

Karyotype

46,XX

Phenotypes

Hypogonadism (HP:0000135); Gynecomastia (HP:0000771)

Diagnosis

46,XY DSD due to 3β-hydroxysteroid dehydrogenase type 2 deficiency (classic salt-wasting form).

Follow-up

Not reported in the original article (under follow-up)

General phenotype

Neonatal hyperpigmentation and undervirilization; no skeletal malformations commonly seen in POR deficiency.

Imaging

Not reported in the original article

Laboratory findings

17-OHP 86 ng/mL, ACTH 250 pg/mL, cortisol 42 μg/L (60–230), DHEAS 1970 μg/L, testosterone 1.3 ng/mL, Δ4-androstenedione 18.5 ng/mL, DHT 26 pg/mL; renin, aldosterone, and electrolytes were normal at initial workup.

Management

Started on hydrocortisone 35 mg/m²/day; on day 18, fludrocortisone 0.05 mg/day and oral NaCl 1 g/day were added.

Pathology

Not reported in the original article

Evidence level

See source

Clinical history

See source

Cite this resource

DSD Research Library | Congenital Adrenal Hyperplasia (CAH) · 46,XX · DSD-T309 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T309?version=v1.4.0